In a Wall Street Journal opinion piece, James Mullen, CEO of Biogen Idec and chairman of BIO, recounts the successes of the biotech industry while warning that "a witch's brew of initiatives" currently proposed by US lawmakers could have a serious impact on the field.
To read the full story....
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.